Viral rebound after Paxlovid therapy — what do we know?
Cases of viral rebound or COVID-19 rebound are being reported after Paxlovid therapy. Here’s what health care practitioners should know about Paxlovid efficacy and rebound.
Read
Cases of viral rebound or COVID-19 rebound are being reported after Paxlovid therapy. Here’s what health care practitioners should know about Paxlovid efficacy and rebound.
Read
With outbreaks occurring simultaneously around the world, DynaMed’s infectious disease team shares what we know about monkeypox.
Read
A new study adds to a growing body of evidence that COVID-19 vaccines do not negatively impact reproductive potential.
Read
Vaccination remains the most effective method to prevent severe outcomes of COVID-19, but what do we know about medications for pre-exposure and post-exposure prophylaxis?
Read
We are entering 2022 with vaccines, treatments, and yes, new variants. Here are answers to ten questions you may have about COVID-19 as we usher in the new year.
Read
Pharmacokinetic profiles guide drug dosing regimens, but how are vaccine dosing regimens determined? DynaMed editors break down this difference and illustrate the influence of age.
Read
Editors at DynaMed share what you need to know about Omicron, the COVID-19 variant that’s spreading rapidly around the globe.
Read
Vaccines and prevention, treatments and complications associated with the disease are among the prevalent themes in these popular COVID-19 ClinicalKey articles published in 2021.
Read
Joule’s Ask a Librarian team curates free evidence-based resources on post‒COVID-19 condition, also known as long COVID.
Read
Molnupiravir is a new antiviral pill to treat COVID-19. Here’s what we know so far.
Read
Answers to common questions about COVID-19 booster shots from medical experts at DynaMed.
Read
DynaMed’s editorial team debunks misinformation about COVID-19 infections in vaccinated people, the delta variant and immunity concerns.
Read
What is the status of SARS-CoV-2 vaccines for children? What do we know about their efficacy and safety for adolescents? The editorial team at DynaMed shares evidence to answer them.
Read
The four highest-rated POEMs for 2020 overall, and 5 of the top 20 highest-rated POEMs for clinical relevance, were on COVID-19 prevention.
Read
The editorial team at DynaMed shares new information on SARS-CoV-2 Variants of Concern including the updated naming convention defined by WHO.
Read
How long does immunity to SARS-CoV-2 last? The editorial team at DynaMed shares the evidence on this topic.
Read
Meta description: What is long COVID? And how do you treat it? The editorial team at DynaMed shares evidence on the condition
Read
Many people are curious about how adenovirus-vectored vaccines work for COVID-19. The editorial team at DynaMed provides a sneak peek.
Read
Millions of people around the world are receiving an mRNA-based vaccine for COVID-19. The editorial team at DynaMed shares how they work.
Read
Editors at Elsevier have identified the top 10 COVID-19 related articles accessed by physicians on ClinicalKey in 2021.
Read
Loading More...